A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1999
12/14/1999	US6001336 Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
12/14/1999	CA2138873C Composition against acne insuring the simultaneous treatment of the superficial and deep layers of the skin, and its use
12/09/1999	WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999	WO1999063114A1 Antisense oligonucleotide modulation of human thymidylate synthase expression
12/09/1999	WO1999063087A1 G-protein coupled receptor, named 2871 receptor
12/09/1999	WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999	WO1999062955A1 Method of designing agonists and antagonists to egf receptor family
12/09/1999	WO1999062929A1 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999	WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	WO1999062890A1 Isothiazole derivatives useful as anticancer agents
12/09/1999	WO1999062560A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999	WO1999062557A1 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
12/09/1999	WO1999062555A1 Remedies for itching containing pgd2 antagonists
12/09/1999	WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999	WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999	WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
12/09/1999	WO1999062528A1 Treatment of arthritis and other similar conditions
12/09/1999	WO1999062527A1 nrdE
12/09/1999	WO1999062524A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999	WO1999062522A1 Combination therapy for treatment of bipolar disorders
12/09/1999	WO1999062513A1 Hiv integrase inhibitors
12/09/1999	WO1999062509A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999	WO1999062505A2 Method for treating neurodegenerative disorders
12/09/1999	WO1999062459A2 Agents and methods for protection, treatment and repair of connective tissue
12/09/1999	WO1999054445A3 Combination therapy using nucleic acids and conventional drugs
12/09/1999	WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
12/09/1999	WO1999051275A3 Mesenchymal stem cells as immunosuppressants
12/09/1999	WO1999051260A3 Treatment of cardiac hypertrophy
12/09/1999	WO1999026583A3 Inhibtion of lipoprotein oxidation
12/09/1999	CA2334117A1 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999	CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	CA2333868A1 Pharmaceutical compositions for the treatment of itching comprising pgd2 receptors antagonists
12/09/1999	CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999	CA2333752A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999	CA2332408A1 Combination therapy for treatment of bipolar disorders
12/09/1999	CA2330833A1 Human minor vault protein p193
12/09/1999	CA2330581A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999	CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/09/1999	CA2329512A1 Il-6/sil-6r complex for promotion of liver functions
12/09/1999	CA2329435A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999	CA2329134A1 Hiv integrase inhibitors
12/09/1999	CA2329132A1 Method of designing agonists and antagonists to egf receptor family
12/09/1999	CA2328891A1 G-protein coupled receptor, named 2871 receptor
12/08/1999	EP0962225A2 Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
12/08/1999	EP0961835A1 Method for identifying selective inhibitors of nitric oxide synthase
12/08/1999	EP0961794A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
12/08/1999	EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999	EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999	EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999	EP0961616A1 Non-hormonal method of contraception
12/08/1999	EP0961613A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
12/08/1999	EP0961612A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
12/08/1999	EP0961610A1 Skin preparation
12/08/1999	EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999	CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999	CN1237979A Conformationally constrained LH-RH analogues, their ues and pharmaceutical composisions containing them
12/08/1999	CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies
12/08/1999	CN1237906A New use for 1,3-propanediol derivatives
12/08/1999	CN1237901A Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof
12/07/1999	US5998588 Interactive molecular conjugates
12/07/1999	US5998473 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester derivatives
12/07/1999	US5998463 Antidiabetic agents; antilipemic agents; anticholesterol agents
12/07/1999	US5998458 Administering inotropic agent and adrenergic receptor antagonist
12/07/1999	US5998423 Methods for modulating melanin production
12/07/1999	US5998408 Autoimmune diseases; antiinflammatory agents
12/07/1999	US5998377 Administration of lh-rh antagonist cetrorelix in combination with at least one .alpha.-reductase inhibitor; without the side effects associated with testosterone levels being in a castration range.
12/07/1999	US5998372 Zinc ring protein
12/07/1999	US5998172 Anti-CD6 ligand antibodies
12/07/1999	US5997885 Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging
12/07/1999	US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/02/1999	WO1999062315A2 Method for altering the activity of proteins of the pka signaling pathway
12/02/1999	WO1999061918A1 Method and means for caries prevention and susceptibility detection
12/02/1999	WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999	WO1999061614A2 Human socs proteins
12/02/1999	WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999	WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999	WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999	WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999	WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999	WO1999061463A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999	WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999	WO1999061453A2 priA
12/02/1999	WO1999061452A2 acpS
12/02/1999	WO1999061431A1 New dipeptidyl peptidase iv effectors
12/02/1999	WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999	WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999	WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999	WO1999061059A1 Minoxidil compositions for external use
12/02/1999	WO1999061050A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA)
12/02/1999	WO1999061047A1 Compound delivery using rapidly dissolving collagen film
12/02/1999	WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999	WO1999061041A1 Novel peptides
12/02/1999	WO1999061027A1 Combination therapy for treatment of refractory depression
12/02/1999	WO1999061024A1 Peripheral benzodiazepine receptor ligands
12/02/1999	WO1999061020A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
12/02/1999	WO1999061019A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
12/02/1999	WO1999061013A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
12/02/1999	WO1999061010A2 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound

1 ... 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 ... 1151